Massachusetts Financial Services’s BioAtla BCAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,317	Closed	-$305K	–	885
2024 Q4	$305K	Sell	10,317 -1,070	-9%	-$89.8K	﹤0.01%	860
2024 Q3	$1M	Buy	11,387 +563	+5%	+$47.2K	﹤0.01%	798
2024 Q2	$741K	Buy	10,824 +295	+3%	+$35.1K	﹤0.01%	812
2024 Q1	$1.81M	Sell	10,529 -54	-0.5%	-$6.71K	﹤0.01%	742
2023 Q4	$1.3M	Buy	10,583 +10	+0.1%	+$867	﹤0.01%	754
2023 Q3	$899K	Sell	10,573 -4,554	-30%	-$580K	﹤0.01%	774
2023 Q2	$2.27M	Sell	15,127 -215	-1%	-$37K	﹤0.01%	697
2023 Q1	$2.06M	Buy	15,342 +2,216	+17%	+$399K	﹤0.01%	714
2022 Q4	$5.41M	Buy	13,126 +2,490	+23%	+$1.03M	﹤0.01%	647
2022 Q3	$4.09M	Buy	10,636 +721	+7%	+$236K	﹤0.01%	663
2022 Q2	$1.41M	Sell	9,915 -75	-0.8%	-$11.9K	﹤0.01%	753
2022 Q1	$2.5M	Buy	9,990 +276	+3%	+$115K	﹤0.01%	735
2021 Q4	$9.53M	Sell	9,714 -71	-0.7%	-$90.8K	﹤0.01%	663
2021 Q3	$14.4M	Buy	9,785 +1,325	+16%	+$2.58M	﹤0.01%	645
2021 Q2	$17.9M	Sell	8,460 -25	-0.3%	-$56.5K	0.01%	627
2021 Q1	$21.6M	Sell	8,485 -1,512	-15%	-$3.88M	0.01%	597
2020 Q4	$17M	Buy	+9,997	New	+$16.7M	0.01%	609